FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1624688314> ?p ?o ?g. }

• W1624688314 endingPage "3050" @default.
• W1624688314 startingPage "3041" @default.
• W1624688314 abstract "Diabetes is a risk factor for erectile dysfunction (ED). The proposed mechanisms responsible for diabetic ED are associated with an increase in reactive oxygen species (ROS) production, overactivity of RhoA/ROCK signaling pathway and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, as seen in experimental models of diabetic rats.The aim of this study was to investigate whether NADPH oxidase inhibitor apocynin can ameliorate Streptozotocin (STZ)-induced diabetes-related ED by reducing the ROS production and inhibiting the activity of RhoA/ROCK signaling pathway.The diabetic rats were treated with and without the NADPH oxidase inhibitor apocynin.Erectile responses were evaluated by determining mean arterial blood pressure (MAP) and intracavernosal pressure (ICP) with electrical stimulation of the cavernous nerve. Levels of mRNA expression were measured by real-time polymerase chain reaction (RT-PCR). Levels of protein expression were examined by Western Blot. ROS production was measured by dihydroethidium (DHE) staining and thiobarbituric acid reactive substances assay.The ratio of Maximum ICP-to-MAP (MaxICP/MAP) was significantly decreased in diabetic ED rats, compared to that of age-matched control rats (P < 0.05). Apocynin improved erectile function of diabetic rats (P < 0.05). Expression levels of RhoA (cytosol), nNOS and eNOS were reduced, compared to those of control rats (P < 0.05). Apocynin significantly elevated their expression levels in diabetic rats (P < 0.05). Expression levels of ROCK1, RhoA (membrane fraction), p-MYPT1 and NADPH oxidase subunits p47(phox) and p67(phox) were increased in diabetic rats when compared to those of control rats (P < 0.05), and it was observed that apocynin significantly reduced their expression levels in diabetic rats (P < 0.05). ROS production was increased in diabetic rats when compared to that of control rats (P < 0.05), the effect of apocynin was a reduction in the ROS production in diabetic rats (P < 0.05).NADPH oxidase inhibitor apocynin can ameliorate diabetes-related ED by reducing the ROS production and inhibiting the activity of RhoA/ROCK signaling pathway." @default.
• W1624688314 created "2016-06-24" @default.
• W1624688314 creator A5030928932 @default.
• W1624688314 creator A5045127642 @default.
• W1624688314 creator A5049927994 @default.
• W1624688314 creator A5065238326 @default.
• W1624688314 creator A5065564993 @default.
• W1624688314 creator A5079886307 @default.
• W1624688314 creator A5082487457 @default.
• W1624688314 creator A5085142676 @default.
• W1624688314 date "2012-12-01" @default.
• W1624688314 modified "2023-10-17" @default.
• W1624688314 title "Apocynin Improves Erectile Function in Diabetic Rats through Regulation of NADPH Oxidase Expression" @default.
• W1624688314 cites W1494463289 @default.
• W1624688314 cites W1988341812 @default.
• W1624688314 cites W1990722453 @default.
• W1624688314 cites W1991127163 @default.
• W1624688314 cites W2000155150 @default.
• W1624688314 cites W2006216384 @default.
• W1624688314 cites W2020241353 @default.
• W1624688314 cites W2022403225 @default.
• W1624688314 cites W2029818480 @default.
• W1624688314 cites W2046632348 @default.
• W1624688314 cites W2047933089 @default.
• W1624688314 cites W2064573161 @default.
• W1624688314 cites W2078288255 @default.
• W1624688314 cites W2089065694 @default.
• W1624688314 cites W2093020946 @default.
• W1624688314 cites W2107524645 @default.
• W1624688314 cites W2110103649 @default.
• W1624688314 cites W2110953677 @default.
• W1624688314 cites W2112184386 @default.
• W1624688314 cites W2116192242 @default.
• W1624688314 cites W2122948438 @default.
• W1624688314 cites W2124559568 @default.
• W1624688314 cites W2127404126 @default.
• W1624688314 cites W2129938192 @default.
• W1624688314 cites W2137377367 @default.
• W1624688314 cites W2138453316 @default.
• W1624688314 cites W2146669232 @default.
• W1624688314 cites W2147290899 @default.
• W1624688314 cites W2150676717 @default.
• W1624688314 cites W2156988103 @default.
• W1624688314 cites W2159214625 @default.
• W1624688314 cites W2159992963 @default.
• W1624688314 cites W2169991415 @default.
• W1624688314 cites W2171546183 @default.
• W1624688314 cites W2403753580 @default.
• W1624688314 doi "https://doi.org/10.1111/j.1743-6109.2012.02960.x" @default.
• W1624688314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23088159" @default.
• W1624688314 hasPublicationYear "2012" @default.
• W1624688314 type Work @default.
• W1624688314 sameAs 1624688314 @default.
• W1624688314 citedByCount "44" @default.
• W1624688314 countsByYear W16246883142012 @default.
• W1624688314 countsByYear W16246883142013 @default.
• W1624688314 countsByYear W16246883142014 @default.
• W1624688314 countsByYear W16246883142015 @default.
• W1624688314 countsByYear W16246883142016 @default.
• W1624688314 countsByYear W16246883142017 @default.
• W1624688314 countsByYear W16246883142018 @default.
• W1624688314 countsByYear W16246883142020 @default.
• W1624688314 countsByYear W16246883142021 @default.
• W1624688314 countsByYear W16246883142022 @default.
• W1624688314 crossrefType "journal-article" @default.
• W1624688314 hasAuthorship W1624688314A5030928932 @default.
• W1624688314 hasAuthorship W1624688314A5045127642 @default.
• W1624688314 hasAuthorship W1624688314A5049927994 @default.
• W1624688314 hasAuthorship W1624688314A5065238326 @default.
• W1624688314 hasAuthorship W1624688314A5065564993 @default.
• W1624688314 hasAuthorship W1624688314A5079886307 @default.
• W1624688314 hasAuthorship W1624688314A5082487457 @default.
• W1624688314 hasAuthorship W1624688314A5085142676 @default.
• W1624688314 hasConcept C126322002 @default.
• W1624688314 hasConcept C133717845 @default.
• W1624688314 hasConcept C134018914 @default.
• W1624688314 hasConcept C181199279 @default.
• W1624688314 hasConcept C185592680 @default.
• W1624688314 hasConcept C2776151105 @default.
• W1624688314 hasConcept C2777093181 @default.
• W1624688314 hasConcept C2777209548 @default.
• W1624688314 hasConcept C2777989768 @default.
• W1624688314 hasConcept C2779719074 @default.
• W1624688314 hasConcept C2779929075 @default.
• W1624688314 hasConcept C38485361 @default.
• W1624688314 hasConcept C48349386 @default.
• W1624688314 hasConcept C55493867 @default.
• W1624688314 hasConcept C555293320 @default.
• W1624688314 hasConcept C62478195 @default.
• W1624688314 hasConcept C71924100 @default.
• W1624688314 hasConcept C98274493 @default.
• W1624688314 hasConceptScore W1624688314C126322002 @default.
• W1624688314 hasConceptScore W1624688314C133717845 @default.
• W1624688314 hasConceptScore W1624688314C134018914 @default.
• W1624688314 hasConceptScore W1624688314C181199279 @default.
• W1624688314 hasConceptScore W1624688314C185592680 @default.
• W1624688314 hasConceptScore W1624688314C2776151105 @default.
• W1624688314 hasConceptScore W1624688314C2777093181 @default.

• next